NCT02442050 - Del Nido Cardioplegia Randomized Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 4, 2017

Study Completion Date

April 4, 2017

Conditions

Cardiac Perfusion

Interventions

OTHER

del Nido solution

1.0-liter of del Nido Cardioplegia after the aortic cross-clamp is applied to the ascending aorta. Delivery of del Nido solution will be administered in a 1:4 ratio of blood:crystalloid at a temperature of 6-10 degrees centigrade.

OTHER

Blood-based cardioplegia

An induction dose of whole blood cardioplegia ranging from 1.0-2.0 liters of solution will be given, with subsequent doses of cardioplegia every 20 minutes.

Trial Locations (2)

22042

CVTSA, Falls Church

Inova Heart and Vascular Institute, Falls Church